Rx Medicare

Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced additional positive safety and efficacy results from its Phase IIb clinical trial known as the Petal Study (603 study) using its proprietary, orally-active non-peptide Gonadotropin-Releasing Hormone (GnRH) receptor antagonist, elagolix, in patients with endometriosis.

Read More…

Related Posts

• Alkermes Announces Positive Results For Phase 1 Study Of New Drug Candidate For Treatment Of Opioid-Induced Constipation
• Study examines course and treatment of unexplained chest pain
• Barriers To Pain Treatment In Children With Sickle Cell Disease Revealed By New Study
• Transdel Pharmaceuticals Announces Positive Phase 3 Study Results For Lead Topical Pain Drug Ketotransdel(R)
• Promising Results In Reducing Neuropathic Pain With Combined Drug Treatment, Than With Either Drug Alone
• Treatment For Chronic Shoulder Pain: Better Results With Exercise Than Shockwave Treatment
• 95% Of Patients In Pain Are Still In Moderate To Severe Chronic Pain Despite One Year Of Treatment
• Valeant Pharmaceuticals Announces Preliminary Results From Its Phase IIa Retigabine Study For The Treatment Of Postherpetic Neuralgia (PHN)
• Extracorporeal Shock Wave Therapy For The Treatment Of Chronic Pelvic Pain Syndrome In Males: A Randomised, Double-Blind, Placebo-Controlled Study
• AcelRx Announces Positive Phase 2 Results From A Study Of ARX-01 Sufentanil NanoTabs In Treating Post-Operative Pain
• Pain Of Dysplasia In Dogs Relieved With Gold Treatment, Study Shows
• KAI Pharmaceuticals Initiates Third Phase 2a Study In Program To Develop KAI-1678 For The Treatment Of Neuropathic Pain
• Study Helps Unravel Mysteries Of Brain’s Endocannabinoid System – NIDA Research Could Lead To Better Treatment For Pain And Marijuana Addiction
• Results Of Pain Management Study On Zen Meditation
• BioElectronics Announces Results Of Menstrual Pain Pilot Clinical Study

Tags: elagolix, endometriosis, full, neurocrine, pain, petal, results, study, treatment, year

This entry was posted on Thursday, May 21st, 2009 at 5:05 am and is filed under Analgesics Pain Migraine. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.